Drugs / Floxuridine, Oxaliplatin, CPT-11
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00695201 | Aug 2000 → Jun 2021 | colon carcinoma, rectal carcinoma | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Floxuridine, Oxaliplatin, CPT-11 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00695201 ↗ |